Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smart software aims to simplify HIV treatment decisions

NCT ID NCT07219862

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 35 times

Summary

This study tests a software tool called smART that helps doctors pick the best combination of HIV drugs for each patient. The tool considers drug resistance, other health conditions, and medication safety. Researchers will compare treatment choices made with and without the tool using 250 patient cases. The goal is to see if the tool helps doctors follow guidelines more closely and make decisions faster.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV (HUMAN IMMUNODEFICIENCY VIRUS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Los Angeles General Medical Center

    Los Angeles, California, 90033, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

smART (Smart Antiretroviral Therapy Assistant) software tool

What this could lead to

If successful, this tool could help general doctors make faster, more accurate HIV treatment decisions, potentially improving patient outcomes.

What could go wrong

This is a small, early-stage study using simulated patient cases, not real-world treatment. The tool may not improve outcomes or be adopted in practice.

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.